Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(8%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_1
2
17%
Ph not_applicable
1
8%
Ph phase_3
2
17%
Ph phase_4
3
25%
Ph phase_2
1
8%

Phase Distribution

2

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(5)
Other(6)

Detailed Status

unknown6
Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 43 (33.3%)
N/A1 (11.1%)

Trials by Status

recruiting18%
unknown650%
completed542%

Recent Activity

1 active trials
Showing 5 of 12
recruitingphase_4

Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa

NCT06554522
completedphase_4

Implementing LISA Surfactant in Nigeria

NCT05714865
completedphase_1

Aerosolized Surfactant in Neonatal RDS

NCT02294630
unknown

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

NCT04568018
unknown

Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study

NCT03479450
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06554522Phase 4

Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa

Recruiting
NCT05714865Phase 4

Implementing LISA Surfactant in Nigeria

Completed
NCT02294630Phase 1

Aerosolized Surfactant in Neonatal RDS

Completed
NCT04568018

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

Unknown
NCT03479450

Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study

Unknown
NCT00233324Phase 3

Surfactant Positive Airway Pressure and Pulse Oximetry Trial

Completed
NCT03440333

Pulmonary Surfactant(PS) Therapy at High Altitude Area

Completed
NCT02825953Not Applicable

Does The Surfactant Administration by Aerosolization Effective?

Unknown
NCT02337192Phase 1

Antimicrobial Photodynamic Therapy Applied in Orthodontic. Orthodontic Patients.

Completed
NCT01723683Phase 2

Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS

Unknown
NCT01265589Phase 3

Intratracheal Vitamin A Administration With Surfactant for Newborn Respiratory Distress Syndrome

Unknown
NCT00277030Phase 4

Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12